price
VN
NASDAQ · VNDA
Vanda Pharmaceuticals Inc.
Healthcare · Biotechnology
$5.44
Down-$0.15 (-2.76%)
Updated Aug 28, 2026, 7:40 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 390.01M
- P/E ratio
- -4.61
- Dividend yield
- 0.00%
- 52-week range
- $4.27 – $9.94
- Volume
- 545.58K
- Avg. volume
- 761.61K
Price performance
VNDA price history
1M range · 21 trading sessions · Daily adjusted prices
VNDA closed at $5.44 after 21 trading sessions, up 5.02% for the selected period.
- Last close
- $5.44
- Period change
- +5.02%
- Period low
- $4.93
- Period high
- $5.57
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 27, 2026 | $5.35 | $5.48 | $5.27 | $5.44 | 545.58K |
| Aug 26, 2026 | $5.43 | $5.43 | $5.24 | $5.35 | 928.37K |
| Aug 25, 2026 | $5.34 | $5.4999 | $5.34 | $5.44 | 876.37K |
| Aug 24, 2026 | $5.335 | $5.37 | $5.20 | $5.33 | 774.3K |
| Aug 21, 2026 | $5.42 | $5.42 | $5.265 | $5.28 | 656.79K |
| Aug 20, 2026 | $5.52 | $5.52 | $5.315 | $5.38 | 915.77K |
| Aug 19, 2026 | $5.50 | $5.59 | $5.39 | $5.57 | 898.03K |
| Aug 18, 2026 | $5.23 | $5.48 | $5.23 | $5.44 | 996.31K |
| Aug 17, 2026 | $5.15 | $5.335 | $5.13 | $5.26 | 795.41K |
| Aug 14, 2026 | $5.04 | $5.28 | $4.955 | $5.22 | 965.07K |
| Aug 13, 2026 | $5.20 | $5.24 | $4.995 | $5.03 | 864.99K |
| Aug 12, 2026 | $4.95 | $5.26 | $4.92 | $5.19 | 1.08M |
| Aug 11, 2026 | $5.05 | $5.09 | $4.849 | $4.93 | 1.07M |
| Aug 10, 2026 | $4.93 | $5.065 | $4.80 | $5.02 | 2M |
| Aug 7, 2026 | $5.16 | $5.17 | $4.97 | $5.00 | 1.31M |
| Aug 6, 2026 | $4.64 | $5.20 | $4.4475 | $5.115 | 2.34M |
| Aug 5, 2026 | $5.33 | $5.41 | $5.04 | $5.09 | 1.6M |
| Aug 4, 2026 | $5.24 | $5.39 | $5.20 | $5.33 | 727.5K |
| Aug 3, 2026 | $5.10 | $5.26 | $5.02 | $5.23 | 719.84K |
| Jul 31, 2026 | $5.16 | $5.16 | $4.95 | $5.10 | 540.61K |
| Jul 30, 2026 | $5.08 | $5.195 | $5.03 | $5.18 | 990.08K |
Latest VNDA news
The latest Smart Investors Daily articles mentioning VNDA.
Stock researchCompany · Financials
Loading stock research…